Abstract 5679: Tetra-specific antibody GNC-035: guidance and navigation control (GNC) molecule development for treatment of ROR1+ malignancies von Khalili, Jahan Salar, Xiao, Sa, Zhu, Yi

Volltext

Abstract 5680: Tetra-specific antibody GNC-039: guidance and navigation control (GNC) molecule development for treatment of EGFRvIII+ malignancies von Khalili, Jahan Salar, Xiao, Sa, Zhu, Yi

Volltext

Abstract 5681: Tetra-specific antibody GNC-038: guidance and navigation gontrol (GNC) molecule development for treatment of CD19+ malignancies von Khalili, Jahan Salar, Xiao, Sa, Zhu, Yi

Volltext

Abstract 6309: Anti-tumor efficacy of SI-B001, a novel EGFR × HER3 bispecific antibody, against EGFR-driven epithelial tumors alone or in combination with paclitaxel and carboplati... von Renshaw, Blair, Khalili, Jahan Salar, Xiao, Sa, Zhu, Yi

Volltext

Abstract 2643: BL-M07D1, a novel HER2-targeting ADC, demonstrates potent anti-tumor efficacy in preclinical pharmacodynamic models von Wan, Weili, Zhao, Shuwen, Zhuo, Shi, Zhang, Yong, Chen, Lan, Li, Gangrui, Khalili, Jahan Salar, Xiao, Sa, Yan, Yongqi, Shen, Xuejiao, Zhu, Yi

Volltext

Abstract 2642: BL-B01D1, a novel EGFR×HER3-targeting ADC, demonstrates robust anti-tumor efficacy in preclinical evaluation von Wan, Weili, Zhao, Shuwen, Zhuo, Shi, Zhang, Yong, Chen, Lan, Li, Gangrui, Renshaw, Blair, Khalili, Jahan Salar, Xiao, Sa, Zhu, Yi

Volltext

Abstract 2644: BL-M02D1, a novel Trop2-targeting ADC, demonstrates robust anti-tumor efficacy in preclinical evaluation von Zhang, Yong, Wan, Weili, Zhuo, Shi, Chen, Lan, Li, Gangrui, Zhao, Shuwen, Khalili, Jahan Salar, Xiao, Sa, Yan, Yongqi, Shen, Xuejiao, Zhu, Yi

Volltext

User-Specific Immunogenic Peptide Informed Diet Suggestion Method von Khalili, Jahan Salar

Volltext bestellen